We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIT icon
276
Applied Industrial Technologies
AIT
$11.9B
$11.3M 0.1%
198,579
-37,409
-16% -$2.1M
TLRA
277
DELISTED
Telaria, Inc.
TLRA
$11.3M 0.1%
1,629,959
-37,000
-2% -$307K
MOD icon
278
Modine Manufacturing
MOD
$10.1B
$11.3M 0.1%
990,534
-102,554
-9% -$1.22M
HNI icon
279
HNI Corp
HNI
$3.38B
$11.3M 0.1%
317,185
-287
-0.1% -$9.52K
QTRX icon
280
Quanterix
QTRX
$121M
$11.2M 0.1%
508,130
-104,900
-17% -$2.93M
UFI icon
281
UNIFI
UFI
$126M
$11.1M 0.1%
508,106
-26,520
-5% -$523K
ANGO icon
282
AngioDynamics
ANGO
$631M
$11.1M 0.1%
604,074
-43,995
-7% -$860K
AVYA
283
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$11.1M 0.1%
1,086,737
+165,000
+18% +$1.94M
TISI icon
284
Team
TISI
$119M
$11.1M 0.1%
61,429
-20,571
-25% -$3.4M
CIEN icon
285
Ciena
CIEN
$45.3B
$11.1M 0.1%
281,906
+7,500
+3% +$314K
VREX icon
286
Varex Imaging
VREX
$778M
$10.9M 0.1%
383,307
+33,927
+10% +$982K
UNTY icon
287
Unity Bancorp
UNTY
$604M
$10.9M 0.1%
492,510
+86,799
+21% +$1.8M
ATEN icon
288
A10 Networks
ATEN
$1.8B
$10.9M 0.1%
1,566,900
+67,200
+4% +$483K
RDN icon
289
Radian Group
RDN
$4.71B
$10.8M 0.1%
475,059
-32,500
-6% -$750K
RCM
290
DELISTED
R1 RCM Inc. Common Stock
RCM
$10.8M 0.1%
1,213,142
+170,414
+16% +$2.01M
BSTC
291
DELISTED
BioSpecifics Technologies Corp.
BSTC
$10.8M 0.1%
202,137
+161,215
+394% +$9.38M
LL
292
DELISTED
LL Flooring Holdings, Inc.
LL
$10.8M 0.1%
1,090,523
+328,578
+43% +$3.22M
FSB
293
DELISTED
Franklin Financial Network, Inc.
FSB
$10.7M 0.1%
355,193
-24,913
-7% -$721K
SLP icon
294
Simulations Plus
SLP
$373M
$10.7M 0.1%
308,556
+28,100
+10% +$990K
BEAT
295
DELISTED
BioTelemetry, Inc.
BEAT
$10.7M 0.1%
262,779
+220,500
+522% +$9.52M
SGRY icon
296
Surgery Partners
SGRY
$1.84B
$10.6M 0.1%
1,430,309
+189,828
+15% +$1.36M
GRC icon
297
Gorman-Rupp
GRC
$1.89B
$10.6M 0.1%
303,260
AMN icon
298
AMN Healthcare
AMN
$1.29B
$10.5M 0.1%
183,152
+4,716
+3% +$261K
GGG icon
299
Graco
GGG
$12.4B
$10.5M 0.1%
227,333
-5,000
-2% -$236K
ACIW icon
300
ACI Worldwide
ACIW
$5.32B
$10.4M 0.1%
331,900
-17,513
-5% -$555K

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.